TP53 MUTATIONS AND DEL17P13 PREDICT SIMILAR OUTCOME AND CHEMOREFRACTORINESS IN CHRONIC LYMPHOCYTIC LEUKEMIA

被引：0
|
作者：
Cerri, M. [1 ]
Deambrogi, C. [1 ]
Capello, D. [1 ]
Cresta, S. [1 ]
Rasi, S. [1 ]
Sozzi, E. [2 ]
De Paoli, L. [1 ]
Gattei, V. [3 ]
Forconi, F. [2 ]
Gaidano, G. [1 ]
Rossi, D. [1 ]
机构：
[1] Amedeo Avogadro Univ, Div Hematol, Novara, Italy
[2] Univ Siena, Div Hematol & Bone Marrow Transplantat, I-53100 Siena, Italy
[3] CRO, Clin & Expt Oncohematol Unit, Aviano, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0410
引用
收藏
页码：163 / 164
页数：2
相关论文
共 50 条
  • [21] FISH Analysis for del6q21 and del17p13 in B-cell Chronic Lymphocytic Leukemia in Iranians
    Teimori, Hossein
    Ashoori, Saeede
    Akbari, Mohamad Taghi
    Naeini, Marjan Mojtabavi
    Chaleshtori, Morteza Hashemzade
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2013, 15 (02) : 107 - 112
  • [22] An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness
    Rigolin, Gian Matteo
    Formigaro, Luca
    Cavallari, Maurizio
    Quaglia, Francesca Maria
    Lista, Enrico
    Urso, Antonio
    Guardalben, Emanuele
    Martinelli, Sara
    Saccenti, Elena
    Bassi, Cristian
    Lupini, Laura
    Bardi, Maria Antonella
    Volta, Eleonora
    Tammiso, Elisa
    Melandri, Aurora
    Negrini, Massimo
    Cavazzini, Francesco
    Cuneo, Antonio
    ONCOTARGET, 2017, 8 (17) : 28008 - 28020
  • [23] HIGH-THROUGHPUT SEQUENCING FOR THE IDENTIFICATION OF TP53 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Barbieri, M.
    Favoino, C.
    Colombo, M.
    Manzoni, M.
    Cutrona, G.
    Matis, S.
    Fabris, S.
    Gentile, M.
    Recchia, A.
    Bossio, S.
    De Stefano, L.
    Fama, A.
    Vincoli, D.
    Musolino, C.
    Molica, S.
    Cortelezzi, A.
    Di Raimondo, F.
    Morabito, F.
    Ferrarini, M.
    Neri, A.
    Lionetti, M.
    HAEMATOLOGICA, 2016, 101 : S26 - S26
  • [24] TP53 mutations at codon 234 are associated with chlorambucil treatment in chronic lymphocytic leukemia
    Lazarian, Gregory
    Theves, Floriane
    Hormi, Myriam
    Letestu, Remi
    Eclache, Virginie
    Bidet, Audrey
    Cornillet-Lefebvre, Pascale
    Davi, Frederic
    Delabesse, Eric
    Estienne, Marie-Helene
    Etancelin, Pascaline
    Kosmider, Olivier
    Laibe, Sophy
    Lode, Laurence
    Muller, Marc
    Nadal, Nathalie
    Naguib, Dina
    Pastoret, Cedric
    Poulain, Stephanie
    Sujobert, Pierre
    Veronese, Lauren
    Imache, Samia
    Lefebvre, Valerie
    Cymbalista, Florence
    Baran-Marszak, Fanny
    Soussi, Thierry
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (04) : E159 - E162
  • [25] Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma
    Lode, Laurence
    Eveillard, Marion
    Trichet, Valerie
    Soussi, Thierry
    Wuilleme, Soraya
    Richebourg, Steven
    Magrangeas, Florence
    Ifrah, Norbert
    Campion, Loic
    Traulle, Catherine
    Guilhot, Francois
    Caillot, Denis
    Marit, Gerald
    Mathiot, Claire
    Facon, Thierry
    Attal, Michel
    Harousseau, Jean-Luc
    Moreau, Philippe
    Minvielle, Stephane
    Avet-Loiseau, Herve
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (11): : 1973 - 1976
  • [26] Evaluation of TP53 Mutations with the AmpliChip p53 Research Test in Chronic Lymphocytic Leukemia: Correlation with Clinical Outcome and Gene Expression Profiling
    Chiaretti, Sabina
    Tavolaro, Simona
    Marinelli, Marilisa
    Messina, Monica
    Del Giudice, Ilaria
    Mauro, Francesca Romana
    Santangelo, Simona
    Piciocchi, Alfonso
    Peragine, Nadia
    Truong, Sim
    Patten, Nancy
    Ghia, Emanuela Maria
    Torrente, Isabella
    De Propris, Maria Stefania
    Nanni, Mauro
    Lawrence, Jeff
    Guarini, Anna
    Foa, Robin
    GENES CHROMOSOMES & CANCER, 2011, 50 (04): : 263 - 274
  • [27] Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia
    Quijada-Alamo, Miguel
    Perez-Carretero, Claudia
    Hernandez-Sanchez, Maria
    Rodriguez-Vicente, Ana-Eugenia
    Herrero, Ana-Belen
    Hernandez-Sanchez, Jesus-Maria
    Martin-Izquierdo, Marta
    Santos-Minguez, Sandra
    Del Rey, Monica
    Gonzalez, Teresa
    Rubio-Martinez, Araceli
    Garcia de Coca, Alfonso
    Davila-Valls, Julio
    Hernandez-Rivas, Jose-Angel
    Parker, Helen
    Strefford, Jonathan C.
    Benito, Rocio
    Ordonez, Jose-Luis
    Hernandez-Rivas, Jesus-Maria
    CLINICAL AND TRANSLATIONAL MEDICINE, 2021, 11 (02):
  • [28] AN EXTENSIVE MOLECULAR CYTOGENETIC CHARACTERIZATION IN HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA IDENTIFIES KARYOTYPE ABERRATIONS AND TP53 DISRUPTION AS PREDICTORS OF OUTCOME AND CHEMOREFRACTORINESS
    Rigolin, G. M.
    Formigaro, L.
    Cavallari, M.
    Quaglia, F. M.
    Lista, E.
    Urso, A.
    Guardalben, E.
    Martinelli, S.
    Saccenti, E.
    Bassi, C.
    Lupini, L.
    Bardi, A.
    Volta, E.
    Tammiso, E.
    Melandri, A.
    Negrini, M.
    Cavazzini, F.
    Cuneo, A.
    HAEMATOLOGICA, 2017, 102 : 419 - 419
  • [29] Characterization of chronic myelomonocytic leukemia with TP53 mutations
    Wang, Wei
    Routbort, Mark J.
    Loghavi, Sanam
    Tang, Zhenya
    Medeiros, L. Jeffrey
    Wang, Sa A.
    LEUKEMIA RESEARCH, 2018, 70 : 97 - 99
  • [30] Characterization of Chronic Myelomonocytic Leukemia with TP53 mutations
    Wang, Wei
    Routbort, Mark
    Loghavi, Sanam
    Tang, Zhenya
    Medeiros, L. Jeffrey
    Wang, Sa
    MODERN PATHOLOGY, 2018, 31 : 563 - 563
12345